Antisense Research and Development · 1994 · 237 citations · 9 references
MedicineImmunologyPharmacologyClinical PharmacologyMolecular PharmacologyPharmacodynamicsAntiretroviral TherapyComplement RegulationComplement SystemComplement-mediated InjuryHemodynamic PharmacologyArterial Blood Pressure MeasurementComplement Activation ModulationComplement Activation PathwaysComplement PharmacokineticsHemodynamic Drug EffectsInfusion Rate EffectsIntravenous Infusion KineticsPhosphorothioate Chemistry
Rapid intravenous infusion of GEM 91, a 25-mer phosphorothioate oligonucleotide complementary to the gag site of HIV, in the monkey produces transient decreases in peripheral total WBC and neutrophil counts, hemoconcentration, and a brief increase followed by a prolonged decrease in arterial blood pressure. These changes are preceded by and are likely mediated by activation of C5 complement. These effects are dose and infusion rate dependent and can be avoided by administering GEM 91 by slow intravenous infusion. Similar hemodynamic effects are produced with rapid intravenous infusion of other phosphorothioate oligonucleotides varying in length from 20- to 33-mer, and are, therefore, not sequence specific but a property of this chemical structure.
9
Rumana Azad, Vickie B. Driver, Keiko Tanaka et al. · Antimicrobial Agents and Chemotherapy · 1993 · 205 citations · Full text
Eliel Bayever, Patrick L. Iversen, Michael Bishop et al. · Antisense Research and Development · 1993 · 150 citations
Medicine, Oncology, Pharmacology +17
Julianna Lisziewicz, Sun D, Frank Weichold et al. · Proceedings of the National Academy of Sciences · 1994 · 119 citations